iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.45 by 8.89 percent. This is a 16.67 percent increase over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $21.979 million which beat the analyst consensus estimate of $21.315 million by 3.12 percent. This is a 12.65 percent increase over sales of $19.511 million the same period last year.